Laurus Labs to acquire stake in Laurus Bio

12 Sep 2023 Evaluate

Laurus Labs has signed Share Purchase agreements with one of the Promoters and non-executive director and his family members and also with few employees/ex-employee shareholders of Laurus Bio for purchase of 37,641 equity shares through secondary purchase. With this acquisition, the shareholding of the Company in Laurus Bio will become 87.58% on fully diluted basis (including outstanding share warrants and ESOP Pool). 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

570.80 3.65 (0.64%)
26-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.50
Dr. Reddys Lab 1355.15
Cipla 1489.20
Lupin 2181.60
Zydus Lifesciences 959.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.